DrugPatentWatch Database Preview
Drugs in Development Information for Lucerastat
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the drug development status for Lucerastat?
Lucerastat is an investigational drug.
There have been 6 clinical trials for Lucerastat.
The most recent clinical trial was a Phase 1 trial, which was initiated on December 15th 2018.
The most common disease conditions in clinical trials are Fabry Disease and [disabled in preview]. The leading clinical trial sponsors are Idorsia Pharmaceuticals Ltd., Actelion, and [disabled in preview].
There are four US patents protecting this investigational drug and sixty-six international patents.
Summary for Lucerastat
| US Patents | 4 |
| International Patents | 66 |
| US Patent Applications | 2 |
| WIPO Patent Applications | 3 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 1 (2018-12-15) |
| Vendors | 16 |
Recent Clinical Trials for Lucerastat
| Title | Sponsor | Phase |
|---|---|---|
| A Study in Healthy Subjects to Investigate Whether Administration of Lucerastat Can Affect Normal Heart Function | Idorsia Pharmaceuticals Ltd. | Phase 1 |
| A Study to Evaluate the Long-term Safety and Tolerability of Lucerastat in Adult Subjects With Fabry Disease | Idorsia Pharmaceuticals Ltd. | Phase 3 |
| Efficacy and Safety of Lucerastat Oral Monotherapy in Adult Subjects With Fabry Disease | Idorsia Pharmaceuticals Ltd. | Phase 3 |
Clinical Trial Summary for Lucerastat
Top disease conditions for Lucerastat
Top clinical trial sponsors for Lucerastat
US Patents for Lucerastat
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Lucerastat | Start Trial | Method for treatment of CNS-involved lysosomal storage diseases | Monsanto Company (St. Louis, MO) | Start Trial |
| Lucerastat | Start Trial | Use of alkylated iminosugars to treat multidrug resistance | G.D. Searle & Company (Chicago, IL) | Start Trial |
| Lucerastat | Start Trial | Use of glucosidase inhibitors for therapy of mucovisidosis | Centre National de la Recherche Scientifique (C.N.R.S.) (Paris, FR) Universite de Poitiers (Poitiers, FR) | Start Trial |
| Lucerastat | Start Trial | Use of glucosidase inhibitors for therapy of mucovisidosis | Centre National de la Recherche Scientifique (C.N.R.S.) (Paris, FR) Universite de Poitiers (Poitiers, FR) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Lucerastat
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Lucerastat | Austria | 148456 | 2013-05-13 | Start Trial |
| Lucerastat | Austria | 268598 | 2013-05-13 | Start Trial |
| Lucerastat | Australia | 5813898 | 2013-05-13 | Start Trial |
| Lucerastat | Australia | 6783294 | 2013-05-13 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
